Grundlæggende statistik
| Institutionelle ejere | 105 total, 97 long only, 0 short only, 8 long/short - change of 1,94% MRQ |
| Gennemsnitlig porteføljeallokering | 0.1666 % - change of -0,16% MRQ |
| Institutionelle aktier (lange) | 102.204.162 (ex 13D/G) - change of -12,00MM shares -10,50% MRQ |
| Institutionel værdi (lang) | $ 276.370 USD ($1000) |
Institutionelt ejerskab og aktionærer
Mereo BioPharma Group plc - Depositary Receipt (Common Stock) (US:MREO) har 105 institutionelle ejere og aktionærer, der har indsendt 13D/G- eller 13F-formularer til Securities Exchange Commission (SEC). Disse institutioner har i alt 102,204,162 aktier. Største aktionærer omfatter Janus Henderson Group Plc, Rubric Capital Management LP, Frazier Life Sciences Management, L.P., Mangrove Partners, Deerfield Management Company, L.p. (series C), Alkeon Capital Management Llc, Rock Springs Capital Management LP, 683 Capital Management, LLC, Clearline Capital LP, and Goldman Sachs Group Inc .
Mereo BioPharma Group plc - Depositary Receipt (Common Stock) (NasdaqCM:MREO) institutionel ejerskabsstruktur viser aktuelle positioner i virksomheden efter institutioner og fonde, samt seneste ændringer i positionsstørrelse. Større aktionærer kan omfatte individuelle investorer, investeringsforeninger, hedgefonde eller institutioner. Skema 13D angiver, at investoren besidder (eller besidder) mere end 5 % af virksomheden og har til hensigt (eller har til hensigt at) aktivt at forfølge en ændring i forretningsstrategi. Skema 13G indikerer en passiv investering på over 5%.
The share price as of September 19, 2025 is 1,73 / share. Previously, on September 20, 2024, the share price was 4,25 / share. This represents a decline of 59,29% over that period.
Fondens stemningsscore
Fund Sentiment Score (fka Ownership Accumulation Score) finder de aktier, der bliver mest købt af fonde. Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af institutionel akkumulering. Scoringsmodellen bruger en kombination af den samlede stigning i oplyste ejere, ændringerne i porteføljeallokeringer i disse ejere og andre målinger. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.
Opdateringsfrekvens: Dagligt
Se Ownership Explorer, som giver en liste over højest rangerende virksomheder.
AI+ Ask Fintel’s AI assistant about Mereo BioPharma Group plc - Depositary Receipt (Common Stock).
Thinking of good questions…
Institutionel Put/Call-forhold
Ud over at indberette standardaktie- og gældsudstedelser skal institutter med mere end 100 mill. aktiver under forvaltning også oplyse deres put- og call-optionsbeholdninger. Da salgsoptioner generelt indikerer negativ stemning, og købsoptioner indikerer positiv stemning, kan vi få en fornemmelse af den overordnede institutionelle stemning ved at plotte forholdet mellem put og kald. Diagrammet til højre viser det historiske put/call-forhold for dette instrument.
Brug af Put/Call Ratio som en indikator for investorernes stemning overvinder en af de vigtigste mangler ved at bruge totalt institutionelt ejerskab, som er, at en betydelig mængde af aktiver under forvaltning investeres passivt for at spore indekser. Passivt forvaltede fonde køber typisk ikke optioner, så indikatoren for put/call-forholdet følger mere nøje følelsen af aktivt forvaltede fonde.
13D/G-arkivering
Vi præsenterer 13D/G ansøgninger separat fra 13F ansøgninger på grund af den forskellige behandling af SEC. 13D/G-ansøgninger kan indgives af grupper af investorer (med én ledende), hvorimod 13F-ansøgninger ikke kan. Dette resulterer i situationer, hvor en investor kan indsende en 13D/G, der rapporterer én værdi for de samlede aktier (der repræsenterer alle de aktier, der ejes af investorgruppen), men derefter indsender en 13F, der rapporterer en anden værdi for de samlede aktier (der udelukkende repræsenterer deres egne) ejendomsret). Det betyder, at aktieejerskab af 13D/G-arkiver og 13F-arkiveringer ofte ikke er direkte sammenlignelige, så vi præsenterer dem separat.
Bemærk: Fra den 16. maj 2021 viser vi ikke længere ejere, der ikke har indsendt en 13D/G inden for det seneste år. Tidligere viste vi den fulde historie af 13D/G-arkiver. Generelt skal enheder, der er forpligtet til at indgive 13D/G-ansøgninger, indgive mindst årligt, før de indsender en afsluttende ansøgning. Dog forlader fonde nogle gange positioner uden at indsende en afsluttende ansøgning (dvs. de afvikler), så visning af den fulde historie resulterede nogle gange i forvirring om det nuværende ejerskab. For at undgå forvirring viser vi nu kun 'aktuelle' ejere - det vil sige - ejere, der har anmeldt inden for det seneste år.
Upgrade to unlock premium data.
| Fil dato | Form | Investor | Forrige Aktier |
Seneste Aktier |
Δ Aktier (Procent) |
Ejendomsret (Procent) |
Δ Ejerskab (Procent) |
|
|---|---|---|---|---|---|---|---|---|
| 2025-08-14 | Frazier Life Sciences Public Fund, L.P. | 40,349,315 | 32,430,690 | -19.63 | 4.10 | -19.61 | ||
| 2025-08-14 | JANUS HENDERSON GROUP PLC | 22,735,121 | 17,688,592 | -22.20 | 11.10 | -22.38 | ||
| 2025-06-11 | Northpond Ventures, LP | 54,521,000 | 6.90 | |||||
| 2025-05-15 | Rock Springs Capital Management LP | 47,670,850 | 33,421,235 | -29.89 | 4.20 | -32.26 | ||
| 2025-05-12 | Adage Capital Management, L.P. | 8,503,780 | 1.07 | |||||
| 2025-02-12 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 50,250,000 | 43,575,065 | -13.28 | 5.62 | -21.62 | ||
| 2024-11-14 | Soleus Private Equity Fund III, L.P. | 48,887,095 | 4,234,765 | -91.34 | 0.50 | -92.86 | ||
| 2024-11-14 | SUVRETTA CAPITAL MANAGEMENT, LLC | 36,854,190 | 0 | -100.00 | 0.00 | -100.00 |
13F og NPORT arkivering
Detaljer om 13F-arkivering er gratis. Detaljer om NP-ansøgninger kræver et premium-medlemskab. Grønne rækker angiver nye positioner. Røde rækker angiver lukkede positioner. Klik på linket ikon for at se den fulde transaktionshistorik.
Opgrader
for at låse premium-data op og eksportere til Excel 
.
| Fil dato | Kilde | Investor | Type | Gennemsnitlig pris (Øst) |
Aktier | Δ Aktier (%) |
Rapporteret Værdi ($1000) |
Δ Værdi (%) |
Port Alloc (%) |
|
|---|---|---|---|---|---|---|---|---|---|---|
| 2025-08-13 | 13F | Renaissance Technologies Llc | 1.480.471 | 9,63 | 4.012 | 32,06 | ||||
| 2025-07-11 | 13F | Grove Bank & Trust | 0 | -100,00 | 0 | |||||
| 2025-08-12 | 13F | MAI Capital Management | 309 | 0,00 | 1 | |||||
| 2025-07-24 | NP | HRTS - Tema Cardiovascular and Metabolic ETF | 115.837 | -56,69 | 249 | -61,15 | ||||
| 2025-08-14 | 13F | Cubist Systematic Strategies, LLC | 21.099 | 57 | ||||||
| 2025-08-07 | 13F | Allworth Financial LP | 1.637 | 9,13 | 4 | 33,33 | ||||
| 2025-08-11 | 13F | Principal Securities, Inc. | 75 | 134,38 | 0 | |||||
| 2025-08-11 | 13F | Knott David M Jr | 319.337 | 0,00 | 865 | 20,47 | ||||
| 2025-08-11 | 13F | Persistent Asset Partners Ltd | Call | 3.035 | 155,90 | 244 | 65,31 | |||
| 2025-08-28 | NP | Tekla World Healthcare Fund | 1.681.804 | 29,33 | 4.558 | 55,79 | ||||
| 2025-07-31 | 13F | Caitong International Asset Management Co., Ltd | 4.544 | 206,20 | 12 | 300,00 | ||||
| 2025-07-18 | 13F | PFG Investments, LLC | 37.433 | 0,00 | 101 | 20,24 | ||||
| 2025-08-14 | 13F | Acuta Capital Partners, Llc | 0 | -100,00 | 0 | |||||
| 2025-08-13 | 13F | NEOS Investment Management LLC | 102.583 | -84,33 | 278 | -81,11 | ||||
| 2025-08-14 | 13F | Millennium Management Llc | Put | 288.700 | 0,00 | 782 | 20,49 | |||
| 2025-08-14 | 13F | Millennium Management Llc | Call | 153.000 | 415 | |||||
| 2025-08-13 | 13F | Level Four Advisory Services, Llc | 10.000 | 0,00 | 27 | 22,73 | ||||
| 2025-08-19 | 13F | Newbridge Financial Services Group, Inc. | 13.000 | 18,18 | 35 | 45,83 | ||||
| 2025-06-12 | 13F | Sheets Smith Investment Management | 16.890 | 0,00 | 38 | -35,59 | ||||
| 2025-08-19 | 13F | Marex Group plc | 10.000 | 27 | ||||||
| 2025-08-14 | 13F | Diadema Partners Lp | Put | 39.400 | 0,00 | 107 | 20,45 | |||
| 2025-08-14 | 13F | Diadema Partners Lp | Call | 1.317.600 | 155,75 | 3.571 | 208,02 | |||
| 2025-08-14 | 13F | Perceptive Advisors Llc | 0 | -100,00 | 0 | -100,00 | ||||
| 2025-08-14 | 13F | Citadel Advisors Llc | 760.659 | 121,35 | 2.061 | 166,62 | ||||
| 2025-08-14 | 13F | Cantor Fitzgerald, L. P. | 342.957 | -3,39 | 929 | 16,42 | ||||
| 2025-08-14 | 13F | Ubs Asset Management Americas Inc | 0 | -100,00 | 0 | |||||
| 2025-08-14 | 13F | Citadel Advisors Llc | Call | 62.200 | -18,69 | 169 | -2,33 | |||
| 2025-08-14 | 13F | Citadel Advisors Llc | Put | 99.800 | 187,61 | 270 | 246,15 | |||
| 2025-08-15 | 13F | Soleus Capital Management, L.P. | 599.711 | -12,70 | 1.625 | 5,18 | ||||
| 2025-08-14 | 13F | Integral Health Asset Management, LLC | 0 | -100,00 | 0 | |||||
| 2025-08-15 | 13F | Morgan Stanley | 785.377 | -63,97 | 2.128 | -56,61 | ||||
| 2025-08-14 | 13F | Caption Management, LLC | 197.599 | 88,58 | 535 | 127,66 | ||||
| 2025-08-14 | 13F | Schonfeld Strategic Advisors LLC | 909.640 | -42,83 | 2.465 | -31,13 | ||||
| 2025-08-14 | 13F | Caption Management, LLC | Call | 437.500 | 43,44 | 1.186 | 72,74 | |||
| 2025-07-14 | 13F | GAMMA Investing LLC | 9.257 | 10,47 | 25 | 38,89 | ||||
| 2025-08-12 | 13F | Jpmorgan Chase & Co | 0 | -100,00 | 0 | |||||
| 2025-08-14 | 13F | Millennium Management Llc | 595.673 | 51,02 | 1.614 | 81,96 | ||||
| 2025-08-14 | 13F | Point72 Asset Management, L.P. | 59.200 | 65,29 | 160 | 100,00 | ||||
| 2025-08-14 | 13F | Susquehanna International Group, Llp | 361.542 | 107,33 | 980 | 149,74 | ||||
| 2025-08-14 | 13F | Susquehanna International Group, Llp | Call | 133.600 | 43,66 | 362 | 73,21 | |||
| 2025-08-14 | 13F | Susquehanna International Group, Llp | Put | 111.600 | 27,11 | 302 | 53,30 | |||
| 2025-04-11 | 13F | Cranbrook Wealth Management, LLC | 0 | -100,00 | 0 | |||||
| 2025-08-12 | 13F | Proequities, Inc. | Put | 0 | 0 | |||||
| 2025-08-12 | 13F | Proequities, Inc. | Call | 0 | 0 | |||||
| 2025-08-14 | 13F | Diadema Partners Lp | 0 | -100,00 | 0 | -100,00 | ||||
| 2025-08-28 | NP | GWX - SPDR(R) S&P(R) International Small Cap ETF | 44.942 | -1,57 | 122 | 18,63 | ||||
| 2025-08-12 | 13F | Proequities, Inc. | 0 | 0 | ||||||
| 2025-08-14 | 13F | Fmr Llc | 1.478.500 | 94,77 | 4.007 | 134,68 | ||||
| 2025-07-24 | 13F | Us Bancorp \de\ | 13 | 0,00 | 0 | |||||
| 2025-08-14 | 13F | Jane Street Group, Llc | Put | 221.700 | 2,02 | 601 | 22,95 | |||
| 2025-08-14 | 13F | Deerfield Management Company, L.p. (series C) | 6.710.429 | 0,00 | 18.185 | 20,45 | ||||
| 2025-06-26 | NP | FBTAX - Fidelity Advisor Biotechnology Fund Class A This fund is a listed as child fund of Fmr Llc and if that institution has disclosed ownership in this security, then these positions will not be double counted when calculating total shares and total value | 759.100 | 1.966 | ||||||
| 2025-08-14 | 13F/A | Forefront Analytics, LLC | 19.138 | -59,82 | 52 | -52,34 | ||||
| 2025-08-14 | 13F | UBS Group AG | 373.505 | -59,93 | 1.012 | -51,74 | ||||
| 2025-05-15 | 13F | Verition Fund Management LLC | 0 | -100,00 | 0 | |||||
| 2025-08-14 | 13F | Clearline Capital LP | 3.618.163 | 12,44 | 9.805 | 35,43 | ||||
| 2025-07-16 | 13F | Signaturefd, Llc | 187 | 1 | ||||||
| 2025-08-08 | 13F | Geode Capital Management, Llc | 92.534 | 0,41 | 251 | 20,77 | ||||
| 2025-08-12 | 13F | Rhumbline Advisers | 9.878 | 49,94 | 27 | 85,71 | ||||
| 2025-08-14 | 13F | Two Sigma Investments, Lp | 659.158 | 168,82 | 1.786 | 224,14 | ||||
| 2025-08-05 | 13F | Simplex Trading, Llc | Put | 25.000 | 7,76 | 0 | ||||
| 2025-08-14 | 13F | Knoll Capital Management, LLC | 260.470 | 0,00 | 706 | 20,31 | ||||
| 2025-08-05 | 13F | Simplex Trading, Llc | 201.141 | 4.785,62 | 1 | |||||
| 2025-08-05 | 13F | Simplex Trading, Llc | Call | 199.200 | 250,09 | 1 | ||||
| 2025-07-14 | 13F | HealthInvest Partners AB | 764.901 | 96,13 | 2.073 | 136,26 | ||||
| 2025-08-12 | 13F | BlackRock, Inc. | 455.365 | 65,97 | 1.234 | 100,00 | ||||
| 2025-08-14 | 13F | Wells Fargo & Company/mn | 230 | -81,30 | 1 | -100,00 | ||||
| 2025-07-15 | 13F | Significant Wealth Partners LLC | 22.261 | 61,65 | 60 | 100,00 | ||||
| 2025-08-07 | 13F | Resources Investment Advisors, LLC. | 18.300 | 0,00 | 50 | 19,51 | ||||
| 2025-08-14 | 13F | Paloma Partners Management Co | 296.659 | 804 | ||||||
| 2025-08-14 | 13F | Janus Henderson Group Plc | 17.688.592 | -22,20 | 48.113 | -8,19 | ||||
| 2025-08-11 | 13F | Persistent Asset Partners Ltd | Put | 2.303 | 2.430,77 | 1.025 | 14.542,86 | |||
| 2025-08-14 | 13F | Alkeon Capital Management Llc | 4.698.100 | 0,00 | 12.732 | 20,44 | ||||
| 2025-08-14 | 13F | J. Goldman & Co LP | 52.384 | -34,01 | 142 | -20,79 | ||||
| 2025-08-14 | 13F | Bnp Paribas Arbitrage, Sa | 3 | 0,00 | 0 | |||||
| 2025-08-14 | 13F | Artia Global Partners LP | 475.361 | 12,82 | 1.288 | 35,86 | ||||
| 2025-08-14 | 13F | ADAR1 Capital Management, LLC | 0 | -100,00 | 0 | |||||
| 2025-07-24 | NP | Tema ETF Trust - Tema Oncology ETF | 147.616 | -43,59 | 317 | -49,52 | ||||
| 2025-08-14 | 13F/A | Skopos Labs, Inc. | 849 | 2 | ||||||
| 2025-08-14 | 13F | 683 Capital Management, LLC | 4.350.000 | -6,15 | 11.788 | 13,04 | ||||
| 2025-05-15 | 13F | Eversept Partners, LP | 0 | -100,00 | 0 | |||||
| 2025-04-18 | 13F | Bfsg, Llc | 0 | -100,00 | 0 | -100,00 | ||||
| 2025-08-13 | 13F | Virtus Investment Advisers, Inc. | 33.825 | -23,14 | 92 | -8,08 | ||||
| 2025-07-14 | 13F | Avanza Fonder AB | 38.235 | 35,97 | 104 | 56,06 | ||||
| 2025-08-13 | 13F | Centiva Capital, LP | 25.000 | 0,00 | 68 | 19,64 | ||||
| 2025-08-12 | 13F | XTX Topco Ltd | 69.341 | 188 | ||||||
| 2025-08-13 | 13F | Hsbc Holdings Plc | 0 | -100,00 | 0 | |||||
| 2025-05-15 | 13F | Blue Owl Capital Holdings LP | 0 | -100,00 | 0 | |||||
| 2025-08-08 | 13F | BIT Capital GmbH | 0 | -100,00 | 0 | -100,00 | ||||
| 2025-08-14 | 13F | LMR Partners LLP | Call | 125.000 | 339 | |||||
| 2025-06-26 | NP | IDNA - iShares Genomics Immunology and Healthcare ETF | 242.039 | -1,85 | 627 | -15,63 | ||||
| 2025-05-15 | 13F | Polar Asset Management Partners Inc. | 0 | -100,00 | 0 | |||||
| 2025-08-14 | 13F | Two Sigma Advisers, Lp | 144.600 | 393,52 | 392 | 501,54 | ||||
| 2025-08-14 | 13F | Mangrove Partners | 8.636.485 | 0,00 | 23.405 | 20,44 | ||||
| 2025-05-14 | 13F | Walleye Capital LLC | 0 | -100,00 | 0 | |||||
| 2025-08-13 | 13F | Marshall Wace, Llp | 767.744 | 0,00 | 2.081 | 20,44 | ||||
| 2025-07-24 | NP | FNCMX - Fidelity Nasdaq Composite Index Fund This fund is a listed as child fund of Fmr Llc and if that institution has disclosed ownership in this security, then these positions will not be double counted when calculating total shares and total value | 92.156 | 0,00 | 198 | -10,41 | ||||
| 2025-05-05 | 13F | Lindbrook Capital, Llc | 0 | -100,00 | 0 | -100,00 | ||||
| 2025-08-07 | 13F | Monaco Asset Management SAM | 395.000 | -5,15 | 1.070 | 14,19 | ||||
| 2025-08-14 | 13F | Hrt Financial Lp | 0 | -100,00 | 0 | |||||
| 2025-08-26 | NP | NORTHERN FUNDS - NORTHERN SMALL CAP CORE FUND Class K | 1.007 | 0,00 | 3 | 0,00 | ||||
| 2025-08-14 | 13F | Rubric Capital Management LP | 15.307.347 | 0,00 | 41.483 | 20,44 | ||||
| 2025-08-08 | 13F | New England Capital Financial Advisors LLC | 300 | 0,00 | 1 | |||||
| 2025-08-14 | 13F | Jane Street Group, Llc | Call | 27.000 | 126,89 | 73 | 180,77 | |||
| 2025-08-14 | 13F | Jane Street Group, Llc | 247.441 | 70,88 | 671 | 106,15 | ||||
| 2025-08-14 | 13F | Frazier Life Sciences Management, L.P. | 9.440.112 | 20,72 | 25.583 | 45,40 | ||||
| 2025-05-15 | 13F | J. Goldman & Co LP | Call | 0 | -100,00 | 0 | -100,00 | |||
| 2025-08-12 | 13F | SRS Capital Advisors, Inc. | 4.000 | 0,00 | 11 | 11,11 | ||||
| 2025-08-14 | 13F | Dauntless Investment Group, LLC | 134.122 | 363 | ||||||
| 2025-08-28 | NP | Tekla Life Sciences Investors | 1.347.068 | 65,88 | 3.651 | 99,78 | ||||
| 2025-08-14 | 13F | Raymond James Financial Inc | 1.570 | 4 | ||||||
| 2025-05-15 | 13F | Manufacturers Life Insurance Company, The | 0 | -100,00 | 0 | |||||
| 2025-05-09 | 13F | GeoWealth Management, LLC | 0 | -100,00 | 0 | |||||
| 2025-08-14 | 13F | Ameriprise Financial Inc | 0 | -100,00 | 0 | |||||
| 2025-05-14 | 13F | Jump Financial, LLC | 0 | -100,00 | 0 | |||||
| 2025-08-14 | 13F | Bank Of America Corp /de/ | 438.661 | -0,00 | 1.189 | 20,36 | ||||
| 2025-08-13 | 13F | Quadrature Capital Ltd | 25.399 | 11,95 | 69 | 35,29 | ||||
| 2025-08-13 | 13F | Tema Etfs Llc | 102.583 | -84,33 | 278 | -81,11 | ||||
| 2025-08-13 | 13F | Tejara Capital Ltd | 2.430.437 | -3,60 | 6.586 | 16,11 | ||||
| 2025-09-04 | 13F/A | Advisor Group Holdings, Inc. | 5.377 | 75,55 | 15 | 133,33 | ||||
| 2025-08-14 | 13F | Woodline Partners LP | 0 | -100,00 | 0 | |||||
| 2025-08-18 | 13F/A | Hudson Bay Capital Management LP | 450.000 | 0,00 | 1.220 | 20,45 | ||||
| 2025-07-14 | 13F | Clear Harbor Asset Management, LLC | 42.000 | 0,00 | 114 | 20,21 | ||||
| 2025-05-14 | 13F | Virtus ETF Advisers LLC | 0 | -100,00 | 0 | |||||
| 2025-08-14 | 13F | State Street Corp | 44.942 | -1,57 | 122 | 18,63 | ||||
| 2025-08-27 | 13F/A | Squarepoint Ops LLC | 20.668 | 15,26 | 56 | 40,00 | ||||
| 2025-08-14 | 13F | Aquatic Capital Management LLC | 26.930 | 73 | ||||||
| 2025-08-14 | 13F | Rock Springs Capital Management LP | 4.465.292 | -33,20 | 12.101 | -19,54 | ||||
| 2025-08-15 | 13F/A | Exome Asset Management LLC | 14.600 | 40 | ||||||
| 2025-08-14 | 13F | Graham Capital Management, L.P. | 21.176 | -57,15 | 57 | -48,65 | ||||
| 2025-07-14 | 13F | Golden State Equity Partners | 19.900 | 0,00 | 54 | 20,45 | ||||
| 2025-08-05 | 13F | GPS Wealth Strategies Group, LLC | 1.500 | 0,00 | 4 | 33,33 | ||||
| 2025-08-14 | 13F | Group One Trading, L.p. | Put | 56.100 | -33,29 | 152 | -19,58 | |||
| 2025-07-24 | 13F | Standard Life Aberdeen plc | 3.028.872 | 38,41 | 8.208 | 66,73 | ||||
| 2025-08-14 | 13F | Sit Investment Associates Inc | 970 | 0,00 | 0 | |||||
| 2025-08-14 | 13F | Group One Trading, L.p. | Call | 489.900 | 13,25 | 1.328 | 36,38 | |||
| 2025-08-18 | 13F/A | Nomura Holdings Inc | 125.000 | 339 | ||||||
| 2025-08-14 | 13F | Goldman Sachs Group Inc | 3.090.068 | 45,35 | 8.374 | 75,08 | ||||
| 2025-08-14 | 13F | Group One Trading, L.p. | 139.559 | 307,10 | 378 | 390,91 | ||||
| 2025-08-13 | 13F | Transce3nd, LLC | 127 | 0,00 | 0 | |||||
| 2025-08-13 | 13F/A | DLD Asset Management, LP | Call | 25.000 | 68 | |||||
| 2025-06-25 | NP | BBC - Virtus LifeSci Biotech Clinical Trials ETF | 44.024 | 170,19 | 114 | 132,65 | ||||
| 2025-08-14 | 13F | Adage Capital Partners Gp, L.l.c. | 0 | -100,00 | 0 | |||||
| 2025-08-11 | 13F | Persistent Asset Partners Ltd | 0 | -100,00 | 0 | -100,00 | ||||
| 2025-08-14 | 13F | Great Point Partners Llc | 0 | -100,00 | 0 | |||||
| 2025-08-13 | 13F | EverSource Wealth Advisors, LLC | 470 | 1 |
